Dr. Vacirca is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 Route 112
Bldg 4
Port Jefferson Station, NY 11776Phone+1 631-574-8354Fax+1 631-509-6559
Education & Training
Stony Brook Medicine/University HospitalFellowship, Hematology and Medical Oncology, 2001 - 2004- Stony Brook Medicine/University HospitalResidency, Internal Medicine, 1998 - 2001
St. George's University School of MedicineClass of 1998
Certifications & Licensure
NY State Medical License 2001 - 2026
CT State Medical License 2019 - 2025
NJ State Medical License 2019 - 2025
SC State Medical License 2019 - 2025
TN State Medical License 2019 - 2025
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2011-2013
- Fellow (FACP) American College of Physicians, 2007
Clinical Trials
- Bendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma Start of enrollment: 2008 Nov 01
- Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant Start of enrollment: 2011 Apr 20
- Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T Start of enrollment: 2012 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 391 citationsRole of matrix metalloproteinases (MMPs) in colorectal cancer.Stanley Zucker, Jeffrey Vacirca
Cancer Metastasis Reviews. 2004-01-01 - 77 citationsBendamustine combined with rituximab for patients with relapsed or refractory diffuse large B cell lymphoma.Jeffrey Vacirca, Peter. I. Acs, Imad A. Tabbara, Peter Rosen, Peter P. Lee
Annals of Hematology. 2014-03-01 - 48 citationsReal‐world outcomes of sipuleucel‐T treatment in PROCEED, a prospective registry of men with metastatic castration‐resistant prostate cancerCelestia S. Higano, Andrew J. Armstrong, A. Oliver Sartor, Nicholas J. Vogelzang, Philip W. Kantoff
Cancer. 2019-12-01
Press Mentions
“It’s Crazy Money”: PBMs and the Need for TransparencyMarch 29th, 2023- Community Oncology: The Next 20 YearsMarch 25th, 2023
- Annexus Health Raises $33 Million to Further Improve Patient Access and AffordabilityAugust 2nd, 2022
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
